<DOC>
	<DOCNO>NCT02758327</DOCNO>
	<brief_summary>The objective study demonstrate change osmolarity time moderate severe dry eye subject treat TheraTears lubricate drop .</brief_summary>
	<brief_title>Evaluation Tear Osmolarity Over Time With Sustained Use Thera Tears Lubricating Drops</brief_title>
	<detailed_description>Symptomatic dry eye subject exhibit significantly high tear osmolarity observe normal subject , think relate inherent tear film instability dry eye disease . Lubricating eye drop frequently prescribe relieve symptom dry eye .</detailed_description>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<mesh_term>Carboxymethylcellulose Sodium</mesh_term>
	<criteria>1 . Is least 21 year age full legal capacity volunteer ; 2 . Has read sign information consent letter ; 3 . Is willing able follow instruction maintain appointment schedule ; 4 . Is diagnosed dry eye syndrome ( least one eye ) , indicate current ocular examination , prior history ( selfreported history dry eye acceptable ) current use treatment dry eye ; 5 . Has minimum osmolarity read 316 mosm/kg baseline visit least one eye osmolarity read least 308 ( bad eye ) least 8 point difference two eye . 1 . Has take part another research study within last 30 day ; 2 . Planned contact lens wear course study ; 3 . Staff investigational site family member site staff family member currently enrol participant ; 4 . Any subject violates washout period use eye drop 72hrs washout period ; 5 . Has know ocular disease* include active ocular infection , inflammation allergy , especially Salzmann 's nodular degeneration , symptomatic conjunctivochalasis , fixation disparity syndrome ; 6 . Restasis use include least 3 month stable.Used Restasis ( similar topical medication ) within last 6 month ; 7 . Has systemic condition opinion investigator may affect dry eye status subject , especially newly diagnose , newly prescribe and/or unstable ; 8 . Is pregnant , lactate plan pregnancy time enrolment ( verbal confirmation necessary ) ; 9 . Use systemic antihistamine , long continuously least 1 month . Use medication : Systemic Antihistamine ( e.g. , Allegra® , Benadryl® , Claritin® , Dimetapp® , Unisom® , Zyrtec® , etc . ) , Isotretinoin ( e.g. , Accutane® , Roaccutane® , Amnesteem® , Claravis® , Isotroin® , Sotret® ) similar medication ; 10 . Has know sensitivity diagnostic pharmaceutical use study ; 11 . Has undergone ocular surgery ( LASIK , Cataract , etc ) within last year ; For purpose study , ocular condition typically associate dry eye status , meibomian gland dysfunction , mild ( i.e . consider clinically relevant ) blepharitis , corneal conjunctival stain consider exclusion .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Tear Osmolarity</keyword>
	<keyword>Keratitis Sicca</keyword>
	<keyword>Ocular Surface Disease</keyword>
	<keyword>TheraTears</keyword>
</DOC>